<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-viruses-12-00838">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Katlama</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Soulie</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Caby</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Denis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Blanc</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Schneider</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Valantin</surname>
    <given-names>M.-A.</given-names>
   </name>
   <name>
    <surname>Tubiana</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kirstetter</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Valdenassi</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia</article-title>
  <source>J. Antimicrob. Chemother.</source>
  <year>2016</year>
  <volume>71</volume>
  <fpage>2646</fpage>
  <lpage>2650</lpage>
  <pub-id pub-id-type="doi">10.1093/jac/dkw186</pub-id>
  <pub-id pub-id-type="pmid">27287235</pub-id>
 </element-citation>
</ref>
